Oncology/Hematology

Chemotherapy

Latest AI and machine learning research in chemotherapy for healthcare professionals.

4,338 articles
Stay Ahead - Weekly Chemotherapy research updates
Subscribe
Browse Categories
Showing 361-380 of 4,338 articles

Explainable artificial intelligence for personalized prognosis in pancreatic cancer: A nationwide study from Taiwan.

Pancreatic cancer is highly aggressive with poor outcomes; current artificial intelligence (AI) prognostic models often lack interpretability and underutilize large-scale data. This study develops an explainable AI prognostic model for pancreatic cancer survival using Taiwan's national registry data, aiming to identify key prognostic factors, their interactions, non-linear relationships, and patie...

Mar 19 2026 41855151

mRNA-based cancer vaccines: A new frontier in personalized immunotherapy.

The advancement of mRNA technology has rejuvenated the cancer treatment immunotherapy field by providing a flexible and scalable platform to generate tumor-associated or patient-specific neoantigens, which induces strong cytotoxic and helper T-cell outcomes and also immunologically stimulates innate immunity in the body at the same time. In contrast to conventional vaccines, mRNA preparations are ...

Mar 18 2026 41861922
Veteran oropharyngeal cancer outcomes in the modern era: a multi-institutional retrospective analysis.

OBJECTIVE: To define oncologic outcomes in Veterans in the modern era using a multi-institutional cohort designed to support development and validatio...

Mar 18 2026 41855673
AI-Derived Electronic Tumor Marker For Cancer Antigen 19-9 Nonproducers With Pancreatic Ductal Adenocarcinoma.

IMPORTANCE: Cancer antigen 19-9 (CA19-9) is used to assess treatment response among patients with pancreatic ductal adenocarcinoma (PDAC); however, ne...

Mar 18 2026 41848749
AI-enhanced precision: boosting pathologist confidence in HER2 ultra-low diagnosis through intelligent re-screening.

Accurate assessment of Human Epidermal Growth Factor Receptor 2 (HER2) immunohistochemistry (IHC) expression, particularly the precise identification ...

Mar 17 2026 41845525
Decoding the immune-tumor synapse for data-driven design of next-generation immunotherapies.

The immunological synapse (IS) formed between cytotoxic CD8+ T lymphocytes (CTLs) and tumor cells represents the critical interface where many immunot...

Mar 17 2026 41850982
Immune checkpoint molecules beyond PD-1 and CTLA-4: emerging targets in autoimmune diseases and cancer immunotherapy.

BACKGROUND: Immune checkpoint molecules are pivotal regulators of immune activation and tolerance, playing critical roles in cancer, autoimmunity, inf...

Mar 17 2026 41842954
Post-ageing guided closed-loop discovery of multi-element alloy catalysts for automotive exhaust purification.

Multi-element alloy catalysts exhibit tunable electronic structures and remarkable thermal stability, making them promising materials for automotive e...

Mar 16 2026 41847147
The iterative shrinkage thresholding algorithm reveals dynamic aging trajectories of human T lymphocytes via multidimensional spectral flow cytometry analysis.

Immunosenescence is a fundamental hallmark of aging, characterized by differential susceptibility across immune cell lineages. T lymphocytes are parti...

Mar 14 2026 41833104
Homologous recombination deficiency in Ovarian cancer: The game-changer for first-line maintenance therapy.

Homologous recombination deficiency (HRD) plays a central role in the pathogenesis and therapeutic vulnerability of epithelial ovarian cancer (EOC), p...

Mar 13 2026 41833892
Artificial intelligence-based analysis of thrombotic and infectious risk factors in peripherally inserted central catheters (PICCs).

INTRODUCTION: Peripherally inserted central catheters (PICCs) are increasingly used in France for prolonged intravenous therapies such as chemotherapy...

Mar 13 2026 41832132
Overview of combined adjuvant strategies for tumor biomarker detection.

Cancer is one of the leading causes of death worldwide, and early tumor detection can significantly reduce mortality rates. Liquid biopsy is a minimal...

Mar 13 2026 41823325
MuTriM: A multiscale deep learning model integrating longitudinal radiomics and pathomic features for predicting recurrence and adjuvant radiation benefit in breast cancer.

PURPOSE: We present MuTriM, a multimodal deep learning model integrating DCE-MRI and whole-slide pathology to predict survival and radiation benefit i...

Mar 12 2026 41850009
Quantification of nitrite in beverages and pickled foods with a high-sensitivity amperometric biosensor enhanced by a multilayer perceptron neural network.

Accurate nitrite detection in beverages and pickled foods is crucial for food safety but remains challenging due to matrix complexity, particularly in...

Mar 12 2026 41738943
CT-based radiomics for predicting the treatment response to PD-1/PD-L1 inhibitors combined with chemotherapy in unresectable gastric cancer.

OBJECTIVE: To develop and validate a CT-based radiomics model to predict immunotherapy response in unresectable gastric cancer and explore its underly...

Mar 12 2026 41817625
Deep learning on histopathological images to predict breast cancer recurrence risk and chemotherapy benefit: a multicentre, model development and validation study.

BACKGROUND: Genomic assays such as Oncotype DX have transformed adjuvant treatment selection for hormone receptor-positive, HER2-negative, early breas...

Mar 11 2026 41831466
Design of an optimal planning framework for cryosurgical treatment of brain tumor using CNN segmentation of MRI images.

This study presents an integrated methodology for pre-operative cryosurgical planning of irregularly shaped brain tumors using two-dimensional MRI dat...

Mar 11 2026 41819035
A metabolic-immune subtype of breast cancer defined by G6PD and SHMT2: From single‑cell dissection to dual-targeted therapy.

Breast cancer heterogeneity limits the precision of current prognostic and therapeutic strategies, underscoring the need for molecular frameworks that...

Mar 10 2026 41819344
Machine learning and logistic regression in estimating survival in patients with high-malignant deep-seated soft tissue sarcomas: development and analysis based on a population-based retrospective cohort.

BACKGROUND AND PURPOSE:  Soft tissue sarcomas are a heterogeneous group of malignant tumors with a high risk of metastasis, primarily to the lungs, ma...

Mar 10 2026 41805979
Development and validation of an interpretable MRI-based multimodal fusion model for predicting lymph node metastasis after neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a multicenter study.

OBJECTIVE: To develop an interpretable multimodal model that integrates pre-treatment Magnetic resonance imaging (MRI)-based deep learning radiomics (...

Mar 9 2026 41801383
Browse Categories